COMP <GO>
INMD vs MRK // NET PROFIT MARGIN
InMode Ltd. (NASDAQ) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: INMD 4
— MRK 7
■ METRIC PARITY
LAST: $13.22 (-2.15%) • MKT CAP: $776.6M
net-margins
—
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
net-margins
28.10%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (INMD VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | INMD | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 78.50% | 74.80% | +3.70 | INMD | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 17.70% | 20.70% | -3.00 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 5.5x | 15.3x | -9.80 | INMD | /valuation <GO> |
| Free Cash Flow Yield | 10.85% | 3.42% | +7.43 | INMD | /fcf-yield <GO> |
| Operating Margin | 23.00% | 34.30% | -11.30 | MRK | /operating-margins <GO> |
| Net Profit Margin ACTIVE | — | 28.10% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | -6.20% | 1.30% | -7.50 | MRK | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 9.20 | 5.19 | +4.01 | INMD | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 7/9 | -3.00 | MRK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 36.3 | 51.7 | -15.40 | MRK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.92 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 18.4x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $776.6M | $361.02B | -$360.24B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | INMD REV | MRK REV | INMD GROSS % | MRK GROSS % | INMD FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $370.5M | $65.01B | 78.5% | 74.8% | $84.3M | $12.36B |
| FY 2024 | $394.8M | $64.17B | 80.3% | 76.3% | $132.0M | $18.10B |
| FY 2023 | $492.0M | $60.12B | — | — | $176.8M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
INMD // BETA —
MRK // BETA 0.92